233 related articles for article (PubMed ID: 12707328)
1. Correction of defects responsible for impaired Qa-2 class Ib MHC expression on melanoma cells protects mice from tumor growth.
Chiang EY; Henson M; Stroynowski I
J Immunol; 2003 May; 170(9):4515-23. PubMed ID: 12707328
[TBL] [Abstract][Full Text] [Related]
2. A nonclassical MHC class I molecule restricts CTL-mediated rejection of a syngeneic melanoma tumor.
Chiang EY; Stroynowski I
J Immunol; 2004 Oct; 173(7):4394-401. PubMed ID: 15383569
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity against disparate tumors is mediated by a nonpolymorphic MHC class I molecule.
Chiang EY; Stroynowski I
J Immunol; 2005 May; 174(9):5367-74. PubMed ID: 15843534
[TBL] [Abstract][Full Text] [Related]
4. Tumor defense by murine cytotoxic T cells specific for peptide bound to nonclassical MHC class I.
Griffiths E; Ong H; Soloski MJ; Bachmann MF; Ohashi PS; Speiser DE
Cancer Res; 1998 Oct; 58(20):4682-7. PubMed ID: 9788622
[TBL] [Abstract][Full Text] [Related]
5. The nonclassical major histocompatibility complex molecule Qa-2 protects tumor cells from NK cell- and lymphokine-activated killer cell-mediated cytolysis.
Chiang EY; Henson M; Stroynowski I
J Immunol; 2002 Mar; 168(5):2200-11. PubMed ID: 11859106
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis.
Johnsen AK; Templeton DJ; Sy M; Harding CV
J Immunol; 1999 Oct; 163(8):4224-31. PubMed ID: 10510359
[TBL] [Abstract][Full Text] [Related]
7. The role of structurally conserved class I MHC in tumor rejection: contribution of the Q8 locus.
Chiang EY; Stroynowski I
J Immunol; 2006 Aug; 177(4):2123-30. PubMed ID: 16887971
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10.
Salazar-Onfray F; Charo J; Petersson M; Freland S; Noffz G; Qin Z; Blankenstein T; Ljunggren HG; Kiessling R
J Immunol; 1997 Oct; 159(7):3195-202. PubMed ID: 9317117
[TBL] [Abstract][Full Text] [Related]
9. A synthetic peptide homologous to functional domain of human IL-10 down-regulates expression of MHC class I and Transporter associated with Antigen Processing 1/2 in human melanoma cells.
Kurte M; López M; Aguirre A; Escobar A; Aguillón JC; Charo J; Larsen CG; Kiessling R; Salazar-Onfray F
J Immunol; 2004 Aug; 173(3):1731-7. PubMed ID: 15265902
[TBL] [Abstract][Full Text] [Related]
10. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.
Kambayashi T; Kraft-Leavy JR; Dauner JG; Sullivan BA; Laur O; Jensen PE
J Immunol; 2004 Feb; 172(3):1661-9. PubMed ID: 14734748
[TBL] [Abstract][Full Text] [Related]
11. TAP expression reduces IL-10 expressing tumor infiltrating lymphocytes and restores immunosurveillance against melanoma.
Zhang QJ; Seipp RP; Chen SS; Vitalis TZ; Li XL; Choi KB; Jeffries A; Jefferies WA
Int J Cancer; 2007 May; 120(9):1935-41. PubMed ID: 17278102
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12.
Rotem-Yehudar R; Winograd S; Sela S; Coligan JE; Ehrlich R
J Exp Med; 1994 Aug; 180(2):477-88. PubMed ID: 7519239
[TBL] [Abstract][Full Text] [Related]
14. Memory phenotype of CD8+ T cells in MHC class Ia-deficient mice.
Kurepa Z; Su J; Forman J
J Immunol; 2003 Jun; 170(11):5414-20. PubMed ID: 12759416
[TBL] [Abstract][Full Text] [Related]
15. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
[TBL] [Abstract][Full Text] [Related]
16. Different MHC class I heavy chains compete with each other for folding independently of beta 2-microglobulin and peptide.
Tourdot S; Nejmeddine M; Powis SJ; Gould KG
J Immunol; 2005 Jan; 174(2):925-33. PubMed ID: 15634915
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor effect associated with down-regulation of MHC class 1 antigen after co-transfection of GM-CSF and IFN-gamma genes in CT26 tumor cells.
Yoon SJ; Lee JC; Kang JO; Lee SG; Heo DS
Anticancer Res; 2001; 21(6A):4031-9. PubMed ID: 11911288
[TBL] [Abstract][Full Text] [Related]
18. Identification of sequences in the human peptide transporter subunit TAP1 required for transporter associated with antigen processing (TAP) function.
Ritz U; Momburg F; Pircher HP; Strand D; Huber C; Seliger B
Int Immunol; 2001 Jan; 13(1):31-41. PubMed ID: 11133832
[TBL] [Abstract][Full Text] [Related]
19. Restoration of the expression of transports associated with antigen processing in human malignant melanoma increases tumor-specific immunity.
Tao J; Li Y; Liu YQ; Wang L; Yang J; Dong J; Wu Y; Shen GX; Tu YT
J Invest Dermatol; 2008 Aug; 128(8):1991-6. PubMed ID: 18385764
[TBL] [Abstract][Full Text] [Related]
20. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
